Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novavax, Inc. - Common Stock
(NQ:
NVAX
)
9.170
-0.580 (-5.95%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax, Inc. - Common Stock
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
65
66
Next >
Novavax Stock Is in Prime Position For Speculation
↗
June 29, 2022
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on Novavax.
Via
InvestorPlace
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
↗
June 28, 2022
As COVID-19 continues to mutate and form new variants, the FDA is calling on the major vaccine manufacturers to create a new composition of the vaccine for adults.
Via
Benzinga
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
↗
June 28, 2022
A panel of experts will decide whether to recommend omicron-specific boosters.
Via
Investor's Business Daily
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
↗
June 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Novavax Stock Is Up 11% Today
↗
June 23, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading higher Thursday after the company announced that its COVID-19 vaccine was recommended for an expanded conditional marketing authorization in the European...
Via
Benzinga
Airline Stocks Fall as American, United Continue to Cut Flights
↗
June 23, 2022
Airline stocks are slipping on Thursday as companies are continuing to cut flights amid pilot shortages and other problems.
Via
InvestorPlace
Short Squeeze Hopes Take Weber (WEBR) Stock 13% Higher
↗
June 23, 2022
Weber (WEBR) stock is on the move Thursday as retail traders push for a short squeeze of the American grill company's shares.
Via
InvestorPlace
Novavax (NVAX) Stock Gains 7% on EMA Recommendations
↗
June 23, 2022
Novavax (NVAX) stock is gaining Thursday on news of a recommendation for the vaccine company's Covid-19 shot for teens in Europe.
Via
InvestorPlace
NOVAVAX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Novavax, Inc. - NVAX
June 17, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
↗
June 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Novavax Stock Can Rally, But It’s Still Facing Many Obstacles
↗
June 16, 2022
Novavax's vaccine will likely be approved by the FDA relatively soon, but NVAX stock is still facing many obstacles.
Via
InvestorPlace
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
↗
June 14, 2022
Here's why its protein-based shot could struggle in the U.S.
Via
Investor's Business Daily
5 Biotech Stocks To Watch During The Week Of June 13
↗
June 13, 2022
Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a...
Via
Benzinga
Stock Market Rally Under Pressure As Indexes Tumble, Breakouts Fail: Weekly Review
↗
June 10, 2022
The 10-year Treasury yield soared above 3% as inflation came in hot.
Via
Investor's Business Daily
What You Missed On Wall Street On Thursday
↗
June 10, 2022
Here are our top five lists with the news and calls moving stocks, that you better not have missed yesterday...
Via
Talk Markets
69 Biggest Movers From Yesterday
↗
June 10, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.
Via
Benzinga
Why Moderna Stock Is Moving Lower Today
↗
June 09, 2022
Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday as vaccine stocks fall in sympathy with Novavax Inc (NASDAQ: NVAX) following reports the FDA's decision on the company's COVID-19 vacci
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
June 09, 2022
Via
Benzinga
Novavax Stock Skids As FDA Leaves Its Covid Vaccine Decision Hanging
↗
June 09, 2022
Two days after advisors recommended the shot, the FDA has yet to make a move.
Via
Investor's Business Daily
Why Novavax Stock Is Falling Today
↗
June 09, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following reports that the U.S. Food and Drug Administration's decision on the company's COVID-19 vaccine could be delayed to review...
Via
Benzinga
HC Wainwright Says Non-mRNA COVID-19 Option Underappreciated
↗
June 08, 2022
HC Wainwright says safety concerns were noted for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, but the strength of data showed that benefit outweighs risks.
Via
Benzinga
Here's What To Watch On Novavax Stock As Latest COVID-19 Vaccine Gains Approval
↗
June 08, 2022
Novavax, Inc (NASDAQ: NVAX) gapped up 10% to start the trading day on Wednesday, but at press time, the stock had given back almost all of its gains to trade mostly flat.
Via
Benzinga
Why This Novavax Analyst Remains Bearish After COVID Vaccine Panel Vote
↗
June 08, 2022
A Bank of America analyst remains bearish on Novavax, Inc (NASDAQ: NVAX) after a regulatory panel approved Novavax’s Emergency Use Authorization request fo
Via
Benzinga
Top Penny Stocks Today: Why IMPP, CYRN and EFOI Are Soaring Wednesday
↗
June 08, 2022
Penny stocks are a hot topic for traders today and we're diving into the top ones that investors will want to keep an eye on for Wednesday!
Via
InvestorPlace
NVAX Stock Price Predictions: Where Will Novavax Go From Here?
↗
June 08, 2022
NVAX stock price predictions are in the spotlight after its vaccine got an unanimous recommendation from the FDA's advisory panel yesterday.
Via
InvestorPlace
Cruise Stocks News: Why Are CCL, RCL and NCLH Sliding Lower Today?
↗
June 08, 2022
Cruise stocks are slipping on Wednesday after losing a battle with environmental groups over new carbon emissions regulations.
Via
InvestorPlace
Is NVAX Stock a Buy? What 3 Pros Say About Novavax Now.
↗
June 08, 2022
Novavax (NVAX) stock is on the move Wednesday as investors react to an update from the FDA about its Covid-19 vaccine for adults.
Via
InvestorPlace
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
↗
June 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Novavax Stock Is Trading Higher Today
↗
June 08, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading higher Wednesday after a committee of independent U.S. Food and Drug Administration (FDA) vaccine advisors voted to recommend Novavax's COVID-19 vaccine...
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, June 8
↗
June 08, 2022
CNBC
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
65
66
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today